https://www.selleckchem.com/pr....oducts/darapladib-sb
The DCA indicated the nomogram-based clinical utility. Receiver operating characteristic (ROC) curves also demonstrated an area under the curve (AUC) of 0.901 [95% confidence interval (CI) 0.894-0.908] in the training cohort and 0.892 (95% CI 0.881-0.903) in the testing cohort. Our proposed novel nomogram potentially serves as an accurate and user-friendly clinical tool to predict occurrence of distant metastases in RCC patients. Our proposed novel nomogram potentially serves as an accurate and user-friendly clinical tool t
Beğen
Yorum Yap
Paylaş
